BioCryst Announces Late Breaker Presentation of Galidesivir (BCX4430) Nonclinical Results in ...

Galidesivir is a broad spectrum antiviral in advanced development under the Animal Rule for the treatment of Ebola virus disease. A Phase 1 clinical … Full Article http://j.gs/5sTq

Click here to read full article